| Course | DNP 965A DPI Project: Part III |
|---|---|
| Topic | Topic 3 |
| Paper type | Results interpretation discussion |
| Length | About 960 words, 3 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | DNP |
| Updated | October 2026 |
Free sample paper for DNP 965A Topic 3
Inside the Fence a Before-and-After Design Allows: Three Explanations for a 9.6-Point Rise in Statin Use, and the One That Cannot Be Excluded
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
DNP-965A: DPI Project: Part III
Topic 3 Assignment
[Instructor Name]
April 1, 2030
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Inside the Fence a Before-and-After Design Allows: Three Explanations for a 9.6-Point Rise in Statin Use, and the One That Cannot Be Excluded
The Fence
The project compared the same 912 patients at two dates, August 31, 2029, and February 28, 2030, before and after six months of nurse care manager outreach in a composite primary care network. It had no concurrent comparison group, because the network required every clinic to start at once. A design of this kind can establish that something changed in these patients over this period and that the change coincided with the outreach. It cannot, on its own, establish that the outreach caused the change, because anything else that happened to the same patients over the same months could produce the same pattern. Threats of this kind, history, maturation, seasonal effects and regression to the mean, are the standard weaknesses of single-group before-and-after designs (Shadish et al., 2002). Everything in this interpretation stays inside that fence.
Three Candidate Explanations
The proportion of the cohort counted as on a statin rose from 57.3 to 67.0 percent. Three explanations are set out together and weighed against evidence the project actually holds.
The first is the intervention. The evidence for it is direct but partial. Of the 130 patients who moved from no statin to a statin, 119 were patients the care managers reached and talked through the decision aid with, and 11 were unreached patients who started at a routine visit. New starts averaged 23 a month during implementation against 9 a month in the baseline months. The timing of the rise on the run chart follows the start of outreach with the one-month lag the extract imposes, and the trend and shift rules were met in January and February. Among reached patients, 56 percent started a statin; among the unreached, 6 percent did.
The second is a concurrent staffing change. In October 2029, the network added 1.5 full-time prescribers at two clinics to reduce appointment waits, and visits per patient in the cohort rose from 1.4 in the baseline months to 1.9 during implementation. More visits mean more chances for a clinician to start a statin without any outreach. The evidence here cuts both ways. Only 11 of the 130 gains came from unreached patients at routine visits, which suggests visits alone produced a small share. But reached patients also had more visits, 2.2 on average, and some of their starts may have happened at a visit the outreach call prompted or that would have happened anyway. The project holds no data that separates the call's effect from the visit's among reached patients.
The third is regression from an unusually poor baseline. If the baseline months had been abnormally low, some rise would be expected without any intervention. The evidence does not support this: the six baseline values ranged from 55.8 to 57.3 percent, a narrow band that rose slowly, and the patients were selected on age and diagnosis, not on a low statin figure in one month. Regression to the mean is an unlikely contributor, and it would in any case have worked on the whole cohort, not only on the patients the outreach reached.
What Can and Cannot Be Excluded
The third explanation can be set aside. The second cannot. The staffing change and the seasonal rise in visits happened at the same time as the outreach, affected the same patients and would push the outcome in the same direction. The comparison with patients aged 55 to 75, who received no outreach, rose 1.4 points over the same months, which suggests that the combination of season and staffing produced a modest rise on its own; but that group was already at 75 percent, closer to a ceiling, and differs in age and insurance, so it cannot serve as a control. The honest position is that the outreach is the most likely explanation for most of the rise, and that an unknown part of it, probably a few points, may belong to more visits with more prescribers.
What Magnitude a Reader Should Expect
Published work sets a reasonable expectation. In a cluster randomized trial in an academic health system, nudges to clinicians raised statin prescribing by 5.5 percentage points over usual care, and nudges to both clinicians and patients by 7.2 points, measured over a comparable period (Adusumalli et al., 2023). A 9.6-point rise here, from outreach with a pended order, sits at the upper end of that range. That is consistent with an effective intervention plus some contribution from concurrent changes, and it would be surprising if outreach alone, in a network with fewer resources than the trial's, had produced substantially more than the trial's best arm. The expectation from the literature therefore supports the bounded reading rather than the larger one.
The Claim, Bounded
The claim the project can make is this: in five of a network's six primary care clinics, for patients from 40 through 54 whose type 2 diabetes the clinics were already managing, the proportion on a statin rose by 9.6 points during six months of nurse care manager outreach with a decision aid and pended orders, most of the rise came from patients the outreach reached, and part of it may reflect more prescriber visits in the same period. It cannot claim the effect would be the same in other networks, with other staffing or in other seasons, and it cannot claim how many patients will still be taking a statin in a year, which the measure does not show. The balancing measure, with muscle symptom contacts among new starters at 13.8 percent against 7.4 percent in the baseline months, is below the harm threshold but belongs in any statement of what the outreach did (American Diabetes Association Professional Practice Committee, 2025).
References
Adusumalli, S., Kanter, G. P., Small, D. S., Asch, D. A., Volpp, K. G., Park, S. H., Gitelman, Y., Do, D., Leri, D., Rhodes, C., VanZandbergen, C., Howell, J. T., Epps, M., Cavella, A. M., Wenger, M., Harrington, T. O., Clark, K., Westover, J. E., Snider, C. K., & Patel, M. S. (2023). Effect of nudges to clinicians, patients, or both to increase statin prescribing: A cluster randomized clinical trial. JAMA Cardiology, 8(1), 23-30. https://doi.org/10.1001/jamacardio.2022.4373
American Diabetes Association Professional Practice Committee. (2025). 10. Cardiovascular disease and risk management: Standards of care in diabetes-2025. Diabetes Care, 48(Suppl. 1), S207-S238. https://doi.org/10.2337/dc25-S010
Shadish, W. R., Cook, T. D., & Campbell, D. T. (2002). Experimental and quasi-experimental designs for generalized causal inference. Houghton Mifflin.
DNP 965A Topic 3 instructions, in plain terms
Topic 3 in DNP-965A asks students to interpret their findings. Strong discussions start by stating what the design allows, then set out candidate explanations for the result and weigh each against evidence the project actually holds, rather than assuming the intervention caused the change. Students should say which explanations can be excluded and which cannot, compare the size of the result with published work to judge whether it is plausible and end with a claim bounded by population, setting and design. Professional experience can suggest explanations but is not evidence for them, and literature should be used to frame the result, not to pad the section. A short table of explanations with the evidence for and against each helps faculty follow the reasoning.
How this DNP 965A Topic 3 example is built
The finished example argues inside a fence it draws early. The design is restated in one paragraph, not as a formality but because everything after it depends on what a before and after comparison at one site can establish. Three candidate explanations for the observed movement are set out together: the intervention, a staffing change that ran concurrently, and regression from an unusually poor baseline quarter. Each is weighed against evidence the project actually holds, and the second cannot be excluded. Published work on comparable interventions establishes what magnitude a reader should expect. Every figure in a sample is illustrative, since the project, its data and its analysis belong to whoever performed them.
Reading the DNP 965A Topic 3 rubric
Faculty reward a result interpreted within the design's limits. An Excellent discussion states that a before-and-after comparison of 912 patients lacks a concurrent control. Credit goes to three explanations weighed against project data, using Shadish, Cook and Campbell on threats to validity. The rubric values admitting that an overlapping staffing change cannot be excluded. Strong discussions compare the 9.6-point rise with Adusumalli and colleagues' 5.5 points, under ADA standards. Top marks go to a bounded claim naming five clinics and managed patients aged 40 to 54. The claim is bounded.
DNP 965A Topic 3 help before you submit
Causal language over a design that cannot carry it is the failure this section punishes most reliably, and it appears as the intervention being credited with a movement no comparison isolates. A second weakness is offering one explanation where three remain consistent with the figures, which reads as advocacy rather than as inquiry. Marks also go for sources cited only where they agree, since a discussion that meets no contrary finding has synthesized nothing at all. Statistical significance treated as practical importance ignores the question the site actually asked. Interpretation that passes over a peculiar baseline period misses the most economical explanation available. Claims about settings the project never touched extend past a single site by assertion.
Get a DNP-965A Topic 3 example written to your instructions
Send the DNP-965A Topic 3 assignment instructions and the rubric your classroom posts, with the design and any sources your section requires. We write a custom example to those criteria, with rival explanations weighed against each other and the literature used to set an expected magnitude, in 24 to 48 hours. The project and its results stay yours. The first one is free.
More DNP 965A papers and DNP samples
- DNP 965A Topic 1: Prespecified Analysis Report
- DNP 965A Topic 2: Results Write-up
- DNP 965A Topic 4: Limitations Statement
- DNP 965A Topic 5: Null Result DQ Pair
- DNP 965A Topic 6: Sustainability Handover Plan
- DNP 965A Topic 7: Dissemination Plan
- DNP 965A Topic 8: Final Defense Preparation
- DNP 966 Topic 3: Data Integrity Report
- DNP 960A Topic 3: Fidelity Monitoring Plan
- DNP 801A Topic 3: Primary Study Collection
- DNP 955 Topic 3: Clinical Question and Population Tightening
DNP 965A Topic 3 questions, answered
Can I say the intervention caused the improvement?
Rarely from this design. A comparison of one site before and after has no concurrent control, so anything else that shifted in the same period remains a live explanation. The defensible sentence names the movement, names the rival explanations, and says which the evidence narrows. Committees mark that restraint above a confident claim the method never supported.
How much literature belongs in a discussion section?
Enough to establish what magnitude a reader should have expected, and enough to include work that disagrees. Synthesis means the sources argue with each other on the page rather than lining up behind the writer. A discussion citing only agreement has assembled support, and anyone reading widely in the field will notice which studies went missing.
Is my professional experience evidence here?
It is the source of the question rather than the answer to it. Years on the floor tell you which explanations are plausible and where a rival one might be hiding, and that is genuinely valuable. What settles the matter is the data and the synthesized literature, so experience belongs in the framing and evidence belongs in the claim.
Where can I find a free DNP 965A Topic 3 sample paper?
The discussion for DNP 965A Topic 3 covers the fence the design allows, three candidate explanations, what can and cannot be excluded, what magnitude to expect and the claim bounded. Post your DNP 965A Topic 3 prompt and get a free paper.
Can I say the outreach caused the rise in DNP 965A Topic 3?
Rarely from this design. A staffing change overlapped the outreach and would raise statin use too, so the claim is that use rose during outreach, not that outreach caused it.